Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2025)

Organogenesis Holdings (ORGO) has 3 years of Deferred Taxes data on record, last reported at $13.5 million in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 575.07% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $7.3 million, changed N/A, while the annual FY2025 figure was $7.3 million, 168.34% up from the prior year.
  • Deferred Taxes reached $13.5 million in Q4 2025 per ORGO's latest filing, up from -$3.8 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $13.5 million in Q4 2025 and bottomed at -$3.8 million in Q3 2025.
  • Average Deferred Taxes over 3 years is $615285.7, with a median of -$1.3 million recorded in 2025.
  • Peak YoY movement for Deferred Taxes: plummeted 240.76% in 2024, then skyrocketed 575.07% in 2025.
  • A 3-year view of Deferred Taxes shows it stood at $2.0 million in 2023, then tumbled by 240.76% to -$2.8 million in 2024, then surged by 575.07% to $13.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were $13.5 million in Q4 2025, -$3.8 million in Q3 2025, and -$1.0 million in Q2 2025.